USA FDA issues alert about Cylert-associated liver toxicity

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1075, 2005-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

US FDA issues early communication about Xigris safety

Reactions Weekly, Vol. 1, Iss. 1239, 2009-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

An FDA Review of Sulfamethazine Toxicity

By Poirier L.A. Doerge D.R. Gaylor D.W. Miller M.A. Lorentzen R.J. Casciano D.A. Kadlubar F.F. Schwetz B.A.

Regulatory Toxicology and Pharmacology, Vol. 30, Iss. 3, 1999-12 ,pp. : 217-222

Academic Press

Access to resources Recommend Favorite

Fibrate-Associated Adverse Effects Beyond Muscle and Liver Toxicity

Current Pharmaceutical Design, Vol. 14, Iss. 6, 2008-02 ,pp. : 574-587

Bentham Science Publishers

Access to resources Recommend Favorite

FDA regulation of assisted reproductive technology in the USA

By Balser David

Reproductive BioMedicine Online, Vol. 5, Iss. 1, 2002-07 ,pp. : 90-91

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

FDA update on ADRs associated with arginine

Reactions Weekly, Vol. 1, Iss. 1259, 2009-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite